Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn’s disease

BackgroundMonoclonal antibodies inhibiting tumour necrosis factor-α (TNFα) signalling pathway (anti-TNFα) have been widely used in Crohn’s disease (CD). However, treatment response varies among patients with CD and the clinical outcome is dependent on single nucleotide polymorphisms (SNP) in TNFα r...

全面介紹

書目詳細資料
Main Authors: Ahmad Qasem, Saleh A Naser, Seela Ramesh
格式: Article
語言:English
出版: BMJ Publishing Group 2019-06-01
叢編:BMJ Open Gastroenterology